Brief: Kintara Therapeutics Inc - On Dec 3, Co Received A Written Notice From Nasdaq
06/12/2021 14:35
Dec 6 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS INC - ON DEC 3, CO RECEIVED A WRITTEN NOTICE FROM
NASDAQ
* KINTARA THERAPEUTICS INC - NASDAQ NOTICE SAID CO NOT IN COMPLIANCE WITH
$1.00
MINIMUM BID PRICE REQUIREMENT
* KINTARA THERAPEUTICS INC - NOTICE DOES NOT RESULT IN IMMEDIATE DELISTING
OF
COMPANY'S COMMON STOCK FROM NASDAQ CAPITAL MARKET
Source: [ID: https://bit.ly/3GmADRJ]
Further company coverage: KTRA.O
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.